Veeva and Vertex talk about the opportunity for UAT process and technology innovations to reduce database build times.
User Acceptance Testing (UAT) is the second most common cause of database build delays. Running your existing process more efficiently may save a few days on a study, but to shorten your build and release times by a few weeks, the UAT process must change.
Using an Agile Design methodology, Veeva cut the study build and release time for Vertex by over 50%. Much of the time savings resulted from implementing an interactive UAT process with real-time updates. During their first two study builds, Veeva and Vertex discussed how a risk-based approach to UAT could save additional time and effort. This whitepaper reflects the conversations between Vikas Gulati, executive director of data management and metrics at Vertex Pharmaceuticals, and Richard Young, vice president of clinical data strategy at Veeva, discussing four ways to reduce the burden and duration of UAT for EDC systems.